Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Intra ocular lens" patented technology

Intra-Ocular Lenses (IOLs) are soft, foldable lenses that are inserted into the eye during cataract surgery to restore your vision. IOLs are available with optics that provide a wide range of visual clarity and focusing capability.

Intra-ocular lens or contact lens exhibiting lardge depth of focus

Circular and annular lens zones are disclosed which, at a given lens area, exhibit a depth of focus of a lens of considerably smaller area. The large depth of focus is achieved by imparting the lens zones a refractive power profile. An assembly of such large depth of focus lens zones represents a lens of large diameter which lens, in polychromatic light, exhibits essentially the same depth of focus as the lens zones from which it is composed.
Owner:FIALA WERNER J

Surgical microscopy system and method for performing eye surgery

A surgical microscopy system comprises microscopy optics for generating an image of an eye under surgery. A pattern generator generates a pattern to be superimposed with the image. An eye-tracker is provided for tracking a position of the superimposed pattern with respect to the image in case of a movement of the eye. The superimposed pattern comprises pattern elements that are equally distributed on first and second circles of different sizes, in order to give assistance when placing a suture during a corneal transplant. The superimposed pattern may also provide an assistance for orientating a toric intra-ocular lens.
Owner:CARL ZEISS MEDITEC AG

Optical devices with reduced chromatic aberration

This invention relates to an optical device such as a soft or rigid contact lens, intra ocular lens (IOL), ocular insert, or spectacle lens that improves visual acuity by reducing chromatic aberration. Chromatic aberration is reduced by filtering or blocking ultraviolet and high energy blue / violet light below about 455 nm and red and infrared light above about 655 nm. This is accomplished by including in the polymer formulations blue / violet absorbing colorants and ultraviolet light absorbers to filter or block light below about 455 nm; and red absorbing colorants and infrared absorbers to filter or block light above about 655 nm. When these materials are used for wavefront designed lenses, vision better than 20 / 20 is attainable.
Owner:THE LAGADO CORP

Methods and compositions for treating eye disorders

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivitis, fungal conjunctivitis, viral conjunctivitis, uveitis, keratic precipitates, macular edema, and inflammation response after intra-ocular lens implantation. The Clostridial toxin may be produced by a Clostridial beratti, a Clostridia butyricum, a Clostridial tetani bacterium and / or a Clostridial botulinum.
Owner:ALLERGAN INC

Accommodating intra-ocular lens system

An implantable, compressible, accommodating intra-ocular lens (IOL) coupled to at least one sensor which detects a signal created by the ciliary muscle. A ciliary sulcus ring can house the at least one sensor, and the sensor can include miniaturized electrodes (ciliary muscle probes) for implanting into the ciliary muscle of the subject. A potentiometer / microcomputer can modulate the ciliary muscle signal detected by the sensor(s) into an electrical signal, and a transmitter sends this electrical signal to a micromotor, which causes compression of the IOL via an annular support ring system, causing a change in the IOL shape. The IOL can be part of an IOL complex including a compressible, accommodating IOL, an external lens membrane, and an annular support ring system. The annular support ring system provides a foundation for the micromotor to compress the IOL.
Owner:VISTA OCULAR

Insertion mode phacoemulsification employing powered iol delivery

A system and method for performing an ocular surgical procedure is provided. The design provides an intra-ocular lens (IOL) to an eye through an incision in the eye by assessing IOL insertion conditions, translating said IOL insertion conditions into a desired force range for insertion of the IOL via the incision, controlling a power source to move the IOL to the eye, monitoring conditions, such as force encountered, while controlling the power source. The design employs feedback of the force encountered and selectively alters force applied based on force encountered.
Owner:JOHNSON & JOHNSON SURGICAL VISION INC

Insertion mode phacoemulsification employing powered IOL delivery

A system and method for performing an ocular surgical procedure is provided. The design provides an intra-ocular lens (IOL) to an eye through an incision in the eye by assessing IOL insertion conditions, translating said IOL insertion conditions into a desired force range for insertion of the IOL via the incision, controlling a power source to move the IOL to the eye, monitoring conditions, such as force encountered, while controlling the power source. The design employs feedback of the force encountered and selectively alters force applied based on force encountered.
Owner:JOHNSON & JOHNSON SURGICAL VISION INC

Drug sustained-release microsphere capable of being embedded in intraocular lens loop and preparation method of drug sustained-release microsphere

InactiveCN104434811AStable structureAntagonize the inflammatory responseAntibacterial agentsSenses disorderMicroorganismMicrosphere
The invention relates to a drug sustained-release microsphere capable of being embedded in intraocular lens loop and a preparation method of the drug sustained-release microsphere. The drug sustained-release microsphere prepared by the provided method can be used for effectively preventing and treating microorganism infection and antagonistic inflammatory reaction after a cataract surgery, reducing the occurrence rate of intraocular inflammation infection after the cataract surgery, and preventing and inhibiting after-cataract, so as to improve visual quality after the surgery. The technical scheme is that according to the drug sustained-release microsphere capable of being embedded in the intraocular lens loop, the drug sustained-release microsphere is formed by mixing drugs and a carrier at the ratio of 1 to (10000-1), and the drug sustained-release microsphere is 100-800mm in diameter. The preparation method of the drug sustained-release microsphere capable of being embedded in the intraocular lens loop sequentially comprises the following steps: (1) mixing the drugs and the carrier according to the ratio and stirring to obtain mixed liquid; (2) condensing fog-like materials in a collecting room to obtain microspheres; and (3) collecting the microspheres and screening the microspheres by virtue of a screen to obtain the microspheres with required diameters; disinfecting, sealing and packaging the microspheres.
Owner:ZHEJIANG UNIV

Polymeric composition for ocular devices

ActiveUS20130109779A1Improved hydrophobic co-polymeric compositionSimple compositionSpectales/gogglesSurgical adhesivesUltraviolet lightsPhotochemistry
Polymeric and co-polymeric compositions useful for preparing ophthalmic and ocular devices, such as implantable intraocular lenses (IOL) and contact lenses, and processes of forming the compositions and devices are provided. The disclosed polymeric or co-polymeric composition may include a curcuminoid compound as a UV-blocker, and is derived from a pre-polymerization mixture of monomers which comprises at least 50 weight percents acrylate monomers and exhibiting visible light transparency and ultraviolet light opacity. The disclosed co-polymeric composition may alternatively, or in addition, be derived from a pre-polymerization mixture of defined monomers.
Owner:DAVE JAGRAT NATAVAR

Intra-Ocular Implant

An intra ocular implant consisting of optical elements, adapted to forming images on the retina, especially useful in treating presbyopic patients, patients with AMD, patients with other diseases of the retina, and patients in which future development of retinal disorders may occur. An intra ocular implant wherein at least one mirror is operationally connected to the action of the ciliary muscle or its effect on the zonules and capsule of the natural lens; and wherein the mirror is adapted to change curvature, position or optical properties, such that bringing a plurality of objects at different distances into focus is facilitated in presbyopic patients. A lens assembly comprising an intra ocular lens and, an adjustable external or contact lens comprising at least in part of light polarizing material; the assembly at least partially polarizes at least part of the central visual field, at least part of the peripheral visual field or both in any angle.
Owner:LIPSHITZ ISAAC +1

IOL insertion device with lubricious coating

An insertion device for an intra-ocular lens (IOL) has a bilaminar, lubricious coating on the surface which contacts the IOL as it is being inserted into the eye. The bilaminar coating includes a highly lubricious top coat, and a polymeric base coat which is both highly adherent to the surface of the insertion device, and which has functional groups capable of grafting the base coat to the top coat. In its completed form, the bilaminar coating is essentially permanent, and exceedingly lubricious when wet, allowing the IOL to be advanced smoothly and without damage through the insertion device. The top coat may include hyaluronan, or another material capable of providing the required lubricity.
Owner:BIOCOAT

Intra-ocular lens optimizer

A vision testing method and apparatus are disclosed, the method including measuring the modulation to a wavefront of light that is imparted by an intra-ocular lens, determining the wavefront modulation necessary to emulate the optical properties of the IOL after it replaces the crystalline lens in a patient's eye, generating a static or dynamic image viewable by a patient, modulating the wavefront of the image remote from the patient to attain the wavefront that necessary to emulate the optical properties of the IOL after it is implanted, and relaying said wavefront to a plane nearby, on, or within the patient's eye. The apparatus includes devices for measuring the modulation to a wavefront of light that is imparted by an intra-ocular lens, determining the wavefront modulation necessary to emulate the optical properties of the IOL after implantation in a patient's eye, generating a static or dynamic image viewable by a patient, modulating the wavefront of the image remote from the patient to attain the wavefront necessary to emulate the optical properties of the IOL after it is implanted, and relaying said wavefront to a plane nearby, on, or within the patient's eye.
Owner:DIGITALVISION

Intraocular lens assembly

The invention provides an intra ocular lens assembly comprising an intra ocular lens structure (IOL) for placement in the capsular bag and securing the IOL in an opening in an anterior part of a capsular bag, with an anterior capsular bag flap surrounding said opening, and a secondary intraocular lens (S-IOL) comprising fixing parts for attaching said S-IOL to said IOL.
Owner:OCULENTIS HLDG

Axial position display system of astigmatic intraocular lens

The invention discloses an astigmatic intraocular lens axial position display system, and the system comprises a host system and a display system; the host system comprises an imager, an analog quantity input module, a calculation module and an output module; the display system comprises a display control adapter and a display, and the output module is connected with the display control adapter. The analog input module comprises an included angle between an axial position and a corneal astigmatism axial position, the calculation module outputs a residual astigmatism amount and an included angle between the residual astigmatism amount and original astigmatism, and the display displays an axial position rotation diagram, a residual astigmatism axial position diagram, the residual astigmatism amount and the included angle between the residual astigmatism amount and the original astigmatism. Compared with the prior art, the device has the advantages that all adjusted variables can be displayed through the displayer after adjustment, the schematic diagram of the placement position of the intraocular lens is displayed, images and parameters are combined clearly, the adjustment of medical staff is facilitated, and the placement accuracy of the intraocular lens is improved.
Owner:福建眼界科技有限公司

Intraocular lens capsular bag injector and intraocular lens capsular bag injection assembly

PendingCN111529127ASolve the problem of not being able to implant intraocular lensesEnsure correct positionIntraocular lensOphthalmologyEngineering
The invention discloses an intraocular lens capsular bag injector and an intraocular lens capsular bag injection assembly. The intraocular lens capsular bag injector comprises an injector head, an injector holding part and an injector handle, wherein the injector head comprises a first hollow pipe body, and a pipeline in the first hollow pipe body is a first pipeline; the injector holding part comprises a second hollow pipe body, and a pipeline in the second hollow pipe body is a second pipeline; the injector handle comprises a handle rod and an injection core which are connected together; theinjector head is connected with the injector holding part; the rear end of the first hollow pipe body is connected with the front end of the second hollow pipe body, and the second pipeline communicates with the first pipeline; the handle rod is located in the second pipeline, and the handle rod can slide in the second pipeline; and the injection core is located in the second pipeline and can move in the second pipeline and the first pipeline. The intraocular lens capsular bag injector is used for implanting an intraocular lens capsular bag.
Owner:复旦大学附属中山医院厦门医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products